CTLA4 and neoplasm: Great anti-tumor efficacy was absorbed by applying these nanoparticles, followed by anti-CTLA4 therapy. This nanoparticle combined therapy encapsulating both NIR heaters and immune-adjuvant TLR agonists can stimulate vaccine-like immune responses